🚀 Sign up Free for Public Company Valuation & Insights!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free Video Highlights
Stryker Corp. 
Healthcare & biotech / Orthopedics, medical and surgical, and neurotechnology and spine applications
At a Glance | Core Facts | Company Due Diligence: | Industry Due Diligence: | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | Web1. Regulatory Risk: Stryker Corporation is subject to the various regulatory bodies, such as the U.S. Food and Drug Administration that can potentially impose constraints on the operations of the company. Changes in regulation or other unforeseen regulatory developments could materially and adversely affect the business of the company.
2. Competition Risk: The medical device market is highly competitive and new technologies are constantly emerging. Stryker Corporation may not be able to keep up with the requirements imposed by new products and technologies, leading to a decline in market share.
3. Reputational Risk: Stryker Corporation has significant brand loyalty, making it vulnerable to any negative publicity. This could have an adverse effect on the reputation of the company and its ability to retain customers and attract new ones.
4. Litigation Risk: Stryker Corporation is exposed to the risk that it may become involved in legal proceedings, including class action lawsuits, in which it may have to pay out damages.
Wait! There's more — sign up for free or log in